|
|
 |
 |
 |
 |
 |
 |
 |
|
Crystallization Screens - JBScreen PEG/Salt |
|
 |
 |
 |
 |
 |

JBScreen PEG/Salt is an effective reagent kit designed for initial screening of crystallization conditions of biological macromolecules.
It comprises high-purity PEG 3350 and PEG 5000 MME, each combined with 48 different salts, thus covering a range of anions and cations most frequently used in bio-crystallography. The unique combination of the reagents allows screening of PEG versus ionic strength, ion type and pH.
Each JBScreen PEG/Salt kit contains 24 unique reagents, 10 ml each. All 96 reagents of JBScreen PEG/Salt 1-4 are also available in a pre-filled deep well block.
All reagents are prepared using chemicals of microselect grade for molecular biology and ultra-pure water, followed by sterile (0.2 µm) filtration.
|

Individual Conditions of all screens are available in 10 ml as well as 100 ml volumes. Please follow this link.
|
|
|
 |
 |
Product |
 |
 |
 |
Cat. No. |
 |
 |
 |
Amount |
 |
 |
 |
Price (EUR) |
 |
 |
 |
Buy |
 |
 |
 |
Downloads |
 |
 |
 |
JBScreen PEG/Salt 1 |
 |
 |
 |
CS-141 |
 |
 |
 |
1 Kit |
 |
 |
 |
150,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
JBScreen PEG/Salt 2 |
 |
 |
 |
CS-142 |
 |
 |
 |
1 Kit |
 |
 |
 |
150,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
JBScreen PEG/Salt 3 |
 |
 |
 |
CS-143 |
 |
 |
 |
1 Kit |
 |
 |
 |
150,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
JBScreen PEG/Salt 4 |
 |
 |
 |
CS-144 |
 |
 |
 |
1 Kit |
 |
 |
 |
150,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
JBScreen PEG/Salt 1 - 4 |
 |
 |
 |
CS-145 |
 |
 |
 |
4 Kits |
 |
 |
 |
450,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
JBScreen PEG/Salt HTS S (1.0 ml per well) |
 |
 |
 |
CS-205S |
 |
 |
 |
1 Block |
 |
 |
 |
140,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
JBScreen PEG/Salt HTS L (1.7 ml per well) |
 |
 |
 |
CS-205L |
 |
 |
 |
1 Block |
 |
 |
 |
225,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|